Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 90
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03092245 | Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial | ||
| NCT03656640 | Trial Assessing Safety and Efficacy of Gammanorm® in Autoimmune Diseases | ||
| NCT01125813 | Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A | ||
| NCT02111590 | Immunoglobulin Dosage and Administration Form in CIDP and MMN | ||
| NCT01012323 | A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases | ||
| NCT01313507 | High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam) | ||
| NCT03344003 | Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq | ||
| NCT03686969 | Study Evaluating Efficacy and Safety of Octanorm in Patients With Dermatomyositis | ||
| NCT05936580 | Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery | ||
| NCT02180763 | Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps | ||
| NCT04651400 | Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection | ||
| NCT03818529 | ATHN 8: Previously Untreated Patients (PUPs) Matter Study | ||
| NCT01712438 | Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients | ||
| NCT02050841 | Octaplas Pediatric Plasma Replacement Trial | ||
| NCT01859754 | Octagam 5% Versus Comparator Post Marketing Trial | ||
| NCT04354129 | Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency. | ||
| NCT04053699 | Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment | ||
| NCT02256917 | Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A | ||
| NCT02267226 | Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery | ||
| NCT04106895 | Use of Fibryga, a Fibrinogen Concentrate in Real World: Retrospective Collection of Clinical Data | ||
| NCT01341912 | Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs) | ||
| NCT00545493 | Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis | ||
| NCT06096116 | Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass | ||
| NCT02972281 | Systematic Search for Primary Immunodeficiency in Adults With Infections | ||
| NCT03369301 | The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency | ||
| NCT02408484 | Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency | ||
| NCT01888484 | Study of Octanorm Subcutaneous IG in Patients With PID | ||
| NCT05935358 | Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study | ||
| NCT04106908 | Effectiveness and Tolerability of Eqwilate in Real-life Conditions | ||
| NCT02503293 | A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push | ||
| NCT04052698 | Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD | ||
| NCT01938378 | Octaplas Pediatric Plasma Exchange Trial | ||
| NCT03348618 | A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) | ||
| NCT00811174 | Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases | ||
| NCT00989196 | Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A | ||
| NCT01992549 | Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII | ||
| NCT01602419 | Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease | ||
| NCT01863758 | Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A | ||
| NCT02303093 | Non-Interventional Study on the Tolerability and Efficacy of IVIG | ||
| NCT04146376 | Von Willebrand Factor in Pregnancy (VIP) Study | ||
| NCT06429787 | Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure | ||
| NCT05523297 | Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery | ||
| NCT02253082 | Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28) | ||
| NCT03793426 | Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency | ||
| NCT02037373 | Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation | ||
| NCT03907241 | CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (OCTANORM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES, INCLUDING (BUT NOT LIMITED TO) THOSE WHO HAVE COMPLETED THE SCGAM-01 TRIAL | ||
| NCT06599697 | The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy | ||
| NCT03677557 | Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment | ||
| NCT04411667 | Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 | ||
| NCT00812565 | Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease |
